Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRolls-Royce Regulatory News (RR.)

Share Price Information for Rolls-Royce (RR.)

Share Price is delayed by 15 minutes
Get Live Data
1,396.20    -15.60 (-1.10%)
Bid:
1,395.80
Ask:
1,396.20
Spread: 0.40 (0.029%)
Market Cap: £115.72b
RR. Live PriceLast checked at - London Stock Exchange

Intraday Rolls-Royce Share Chart

Director/PDMR Shareholding

1 Dec 2025 17:00

RNS Number : 7502J
Rolls-Royce Holdings plc
01 December 2025
 

1 December 2025

Rolls-Royce Holdings plc

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Rolls-Royce Holdings plc (the Company) announces that the following person(s) discharging managerial responsibilities transacted in ordinary shares of 20p each in the Company (Shares) under the Rolls-Royce Incentive Plan, as set out in the remuneration policy approved by shareholders at the 2025 AGM.

Vesting of awards

The following Shares vested on 28 November 2025 in relation to awards made on 28 November 2023 following a percentage of base salary being deferred into Shares for two years under the Rolls-Royce Incentive Plan.

PDMR

Shares vested

Shares sold to cover statutory withholding liabilities

Shares retained

Tufan Erginbilgic

13,010

6,128

6,882

Helen McCabe

5,029

2,369

2,660

 

The salary deferred Shares above includes accumulated dividends during the vesting periods which were reinvested in Shares on 28 November 2025 based on the average mid-market closing price on the three days leading up to and including the relevant dividend record dates.

PDMR

Share price

Number of shares

Tufan Erginbilgic

£7.182

107

£10.7883

54

Helen McCabe

£7.182

41

£10.7883

20

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Tufan Erginbilgic

2

Reason for the notification

 

a)

Position/status

Chief Executive

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Rolls-Royce Holdings plc

b)

LEI

213800EC7997ZBLZJH69

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

 

Ordinary Shares of 20p each

 

GB00B63H8491

Transaction 1

b)

 

Nature of the transaction

Vest of Shares received in lieu of a percentage of base salary, including accumulated dividends reinvested in Shares

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

 

 

Price(s)

 

Volume(s)

Nil

12,849

£7.182

107

£10.7883

54

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

13,010

 

£1,351.04

e)

Date of the transaction

28 November 2025

f)

Place of the transaction

Outside a trading venue

Transaction 2

b)

Nature of the transaction

Sale of Shares to cover statutory withholding liabilities

c)

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

 

Volume(s)

£10.645

6,128

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

6,128

 

£65,232,56

e)

Date of the transaction

28 November 2025

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Helen McCabe

2

Reason for the notification

 

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Rolls-Royce Holdings plc

b)

LEI

213800EC7997ZBLZJH69

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

 

Ordinary Shares of 20p each

 

GB00B63H8491

Transaction 1

b)

 

Nature of the transaction

Vest of Shares received in lieu of a percentage of base salary, including accumulated dividends reinvested in Shares

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

 

Price(s)

 

Volume(s)

Nil

4,968

£7.182

41

£10.7883

20

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

5,029

 

£510.23

e)

Date of the transaction

28 November 2025

f)

Place of the transaction

Outside a trading venue

Transaction 2

b)

Nature of the transaction

Sale of Shares to cover statutory withholding liabilities

c)

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

 

Volume(s)

£10.645

2,369

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

2,369

 

£25,218.01

e)

Date of the transaction

28 November 2025

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

Name of officer of issuer responsible for making notification: Matthew Conacher

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUBDDCSGDGUB
Date   Source Headline
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20251:00 pmRNSDirector/PDMR Shareholding
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20253:00 pmRNSDirector/PDMR Shareholding
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20255:00 pmRNSHolding(s) in Company
11th Mar 20259:30 amRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20259:02 amRNSAGM Statement
6th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20253:00 pmRNSDirector/PDMR Shareholding
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20259:37 amRNSDirector/PDMR Shareholding
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:05 amRNSShare buyback programme of up to £1 billion
27th Feb 20257:00 amRNSFull Year Results 2024
10th Feb 20252:30 pmRNSDirector/PDMR Shareholding
4th Feb 20253:30 pmRNSTotal Voting Rights
28th Jan 202511:30 amRNSDirector/PDMR Shareholding
9th Jan 202511:30 amRNSDirector/PDMR Shareholding
11th Dec 202410:00 amRNSDirector/PDMR Shareholding
22nd Nov 20241:00 pmRNSDirector Declaration
11th Nov 20241:30 pmRNSDirector/PDMR Shareholding
7th Nov 20247:00 amRNSTrading Update
9th Oct 20249:05 amRNSDirector/PDMR Shareholding
26th Sep 202412:00 pmRNSDirector/PDMR Shareholding
16th Sep 202410:30 amRNSDirector/PDMR Shareholding
11th Sep 20249:15 amRNSDirector/PDMR Shareholding
28th Aug 20242:05 pmRNSDirector/PDMR Shareholding
16th Aug 20241:30 pmRNSDirector/PDMR Shareholding
9th Aug 202411:15 amRNSDirector/PDMR Shareholding
2nd Aug 20249:00 amRNSTotal Voting Rights
1st Aug 20247:00 amRNS2024 Half Year Results
9th Jul 20243:30 pmRNSDirector/PDMR Shareholding
1st Jul 202411:00 amRNSTotal Voting Rights
25th Jun 20242:01 pmRNSAdmission of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.